Related Experiment Video
Updated: May 21, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondrial Reactive Oxygen Species (mROS) Generation and Cancer: Emerging Nanoparticle Therapeutic Approaches
Xinyao Wang1,2, Xiangyang Xiong1,3
1The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
Abstract:
Mitochondrial reactive oxygen species (mROS) are generated as byproducts of mitochondrial oxidative phosphorylation. Changes in mROS levels are involved in tumorigenesis through their effects on cancer genome instability, sustained cancer cell survival, metabolic reprogramming, and tumor metastasis. Recent advances in nanotechnology offer a promising approach for precise regulation of mROS by either enhancing or depleting mROS generation. This review examines the association between dysregulated mROS levels and key cancer hallmarks. We also discuss the potential applications of mROS-targeted nanoparticles that artificially manipulate ROS levels in the mitochondria to achieve precise delivery of antitumor drugs.
Insights
Mitochondrial reactive oxygen species (mROS) impact cancer progression. Nanotechnology offers new ways to control mROS for cancer therapy by targeting mitochondria and delivering drugs.
Area of Science:
- Biochemistry
- Oncology
- Nanotechnology
Background:
- Mitochondrial reactive oxygen species (mROS) are byproducts of cellular respiration.
- Altered mROS levels are linked to cancer hallmarks like genome instability and metastasis.
Purpose of the Study:
- To review the role of mROS in cancer.
- To explore nanotechnology-based strategies for mROS regulation in cancer treatment.
Main Methods:
- Literature review on mROS in cancer.
- Analysis of nanotechnology applications for mROS manipulation.
Main Results:
- Dysregulated mROS contribute to cancer progression.
- Nanoparticles can precisely modulate mitochondrial ROS levels.
Conclusions:
- Targeting mROS offers a promising therapeutic strategy.
- Nanotechnology enables mitochondria-specific ROS manipulation for drug delivery.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitochondria
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

